2-70981947-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001115116.2(ANKRD53):āc.629A>Gā(p.Asn210Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000757 in 1,584,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001115116.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD53 | NM_001115116.2 | c.629A>G | p.Asn210Ser | missense_variant | 4/6 | ENST00000360589.4 | |
LOC105374795 | XR_001739534.2 | n.439+1746T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD53 | ENST00000360589.4 | c.629A>G | p.Asn210Ser | missense_variant | 4/6 | 2 | NM_001115116.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000131 AC: 3AN: 229322Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 124318
GnomAD4 exome AF: 0.00000419 AC: 6AN: 1432774Hom.: 0 Cov.: 31 AF XY: 0.00000422 AC XY: 3AN XY: 710960
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.629A>G (p.N210S) alteration is located in exon 4 (coding exon 4) of the ANKRD53 gene. This alteration results from a A to G substitution at nucleotide position 629, causing the asparagine (N) at amino acid position 210 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at